{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:01:22Z","timestamp":1774393282505,"version":"3.50.1"},"reference-count":47,"publisher":"Portland Press Ltd.","issue":"7","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis B virus (HBV) pregenomic RNA (pgRNA) is a new biomarker that reflects HBV replication, but its relationship with natural killer (NK) cell immunity in chronic hepatitis B (CHB) is unknown. We assessed serum HBV pgRNA levels in 323 CHB patients by reverse transcription-polymerase chain reaction, assessed cytokine production and activation and inhibitory markers of NK cells by flow cytometry, and measured serum cytokines by enzyme-linked immunosorbent assays (ELISAs). Among the different CHB phases, the serum HBV pgRNA level was highest in the immune-tolerant (IT) and immune-active (IA) phases. Regarding NK and NKdim cells, HBV pgRNA was negatively associated with frequencies, but positively associated with NKp44 and NKp46 expression (activation markers). Regarding NKbright cells, serum HBV pgRNA was positively associated with frequency and programmed cell death protein 1 (PD1) expression (inhibitory marker), but negatively associated with NKp44 and NKp46. Serum HBV pgRNA was not associated with NKp30 (activation marker) on NK cells or subsets. Lastly, serum HBV pgRNA was positively correlated with the levels of serum IL-7 and IL-12P40 (NK cell-promoting cytokines) and negatively correlated with serum prostaglandin E2 (PGE2) level (which negatively regulates NK cells). In conclusion, we found varied relationships between serum HBV pgRNA and NK cells and subsets, indicating that HBV pgRNA may play a complicated role in NK cell-related immunity, providing new information on HBV and host immunity.<\/jats:p>","DOI":"10.1042\/bsr20210600","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T04:57:28Z","timestamp":1624251448000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum HBV pregenomic RNA exhibited opposite associations with NKdim and NKbright cell immunity in treatment-na\u00efve chronic hepatitis B patients"],"prefix":"10.1042","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9178-8205","authenticated-orcid":false,"given":"Yurong","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zexuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youming","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhong","family":"Liao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Bi","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-7246","authenticated-orcid":false,"given":"Yuehua","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"},{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"2021111620490911500_B1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1386-6532(05)00384-7","article-title":"Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention","volume":"34","author":"Lavanchy","year":"2005","journal-title":"J. Clin. Virol."},{"key":"2021111620490911500_B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"2021111620490911500_B3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O\u2019Brien","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"2021111620490911500_B4","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1186\/ar4373","article-title":"Natural killer cells and natural killer T cells in Lyme arthritis","volume":"15","author":"Katchar","year":"2013","journal-title":"Arthritis Res. Therapy"},{"key":"2021111620490911500_B5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"2021111620490911500_B6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fimmu.2014.00258","article-title":"The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection","volume":"5","author":"Schuch","year":"2014","journal-title":"Front. Immunol."},{"key":"2021111620490911500_B7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/gut.2008.163600","article-title":"Early kinetics of innate and adaptive immune responses during hepatitis B virus infection","volume":"58","author":"Fisicaro","year":"2009","journal-title":"Gut"},{"key":"2021111620490911500_B8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhep.2010.07.009","article-title":"Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B","volume":"54","author":"Tjwa","year":"2011","journal-title":"J. Hepatol."},{"key":"2021111620490911500_B9","doi-asserted-by":"publisher","first-page":"e86927","DOI":"10.1371\/journal.pone.0086927","article-title":"Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"key":"2021111620490911500_B10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1053\/j.gastro.2009.05.047","article-title":"Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections","volume":"137","author":"Oliviero","year":"2009","journal-title":"Gastroenterology"},{"key":"2021111620490911500_B11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12967-017-1318-1","article-title":"Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment","volume":"15","author":"Li","year":"2017","journal-title":"J. Transl. Med."},{"key":"2021111620490911500_B12","doi-asserted-by":"publisher","first-page":"e1005788","DOI":"10.1371\/journal.ppat.1005788","article-title":"Interferon alpha induces sustained changes in NK cell responsiveness to hepatitis B viral load suppression in vivo","volume":"12","author":"Gill","year":"2016","journal-title":"PLoS Pathog."},{"key":"2021111620490911500_B13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.intimp.2016.06.015","article-title":"Hepatitis B virus antigens impair NK cell function","volume":"38","author":"Yang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"2021111620490911500_B14","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/infdis\/jiy097","article-title":"Increased NK cell function after cessation of long-term nucleos(t)ide analogue treatment in chronic hepatitis B is associated with liver damage and HBsAg loss","volume":"217","author":"Zimmer","year":"2018","journal-title":"J. Infect. Dis."},{"key":"2021111620490911500_B15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jmv.25612","article-title":"Serum HBV pregenomic RNA is correlated with Th1\/Th2 immunity in treatment-naive chronic hepatitis B patients","volume":"92","author":"Gu","year":"2020","journal-title":"J. Med. Virol."},{"key":"2021111620490911500_B16","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"2021111620490911500_B17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.4049\/jimmunol.131.4.1789","article-title":"Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens","volume":"131","author":"Lanier","year":"1983","journal-title":"J. Immunol."},{"key":"2021111620490911500_B18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/1521-4141(200103)31:3%3c792::AID-IMMU792%3e3.0.CO;2-U","article-title":"Interleukin-1beta costimulates interferon-gamma production by human natural killer cells","volume":"31","author":"Cooper","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"2021111620490911500_B19","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.4049\/jimmunol.162.8.4511","article-title":"Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response","volume":"162","author":"Fehniger","year":"1999","journal-title":"J. Immunol."},{"key":"2021111620490911500_B20","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood"},{"key":"2021111620490911500_B21","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J. Immunol."},{"key":"2021111620490911500_B22","first-page":"63","article-title":"Diversification and functional specialization of human NK cell subsets","volume":"395","author":"Cichicki","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"2021111620490911500_B23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"2021111620490911500_B24","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"key":"2021111620490911500_B25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jaut.2016.04.003","article-title":"Dysregulation of regulatory CD56(bright) NK cells\/T cells interactions in multiple sclerosis","volume":"72","author":"Laroni","year":"2016","journal-title":"J. Autoimmun."},{"key":"2021111620490911500_B26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.4049\/jimmunol.1500591","article-title":"CD56brightCD16- NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation","volume":"195","author":"Morandi","year":"2015","journal-title":"J. Immunol."},{"key":"2021111620490911500_B27","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111620490911500_B28","doi-asserted-by":"publisher","first-page":"198085","DOI":"10.1016\/j.virusres.2020.198085","article-title":"NK cells contribute to hepatic CD8 T cell failure in hepatitis B virus-carrier mice after alcohol consumption","volume":"286","author":"Jiang","year":"2020","journal-title":"Virus Res."},{"key":"2021111620490911500_B29","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1136\/gutjnl-2017-314098","article-title":"Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"key":"2021111620490911500_B30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J. Exp. Med."},{"key":"2021111620490911500_B31","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/hep.28155","article-title":"Natural killer cell phenotype modulation and natural killer\/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B","volume":"62","author":"Boni","year":"2015","journal-title":"Hepatology"},{"key":"2021111620490911500_B32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J. Exp. Med."},{"key":"2021111620490911500_B33","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.jhep.2016.01.028","article-title":"The role of innate immunity in the immunopathology and treatment of HBV infection","volume":"64","author":"Maini","year":"2016","journal-title":"J. Hepatol."},{"key":"2021111620490911500_B34","doi-asserted-by":"publisher","first-page":"13825","DOI":"10.1073\/pnas.202398599","article-title":"Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection","volume":"99","author":"Yang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111620490911500_B35","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1128\/JVI.01022-08","article-title":"Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus","volume":"82","author":"Guy","year":"2008","journal-title":"J. Virol."},{"key":"2021111620490911500_B36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","article-title":"Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms","volume":"32","author":"Webster","year":"2000","journal-title":"Hepatology"},{"key":"2021111620490911500_B37","doi-asserted-by":"publisher","first-page":"e1004210","DOI":"10.1371\/journal.ppat.1004210","article-title":"Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver","volume":"10","author":"Jo","year":"2014","journal-title":"PLoS Pathog."},{"key":"2021111620490911500_B38","doi-asserted-by":"publisher","first-page":"e0160171","DOI":"10.1371\/journal.pone.0160171","article-title":"Altered immune profiles of natural killer cells in chronic hepatitis B patients: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS ONE"},{"key":"2021111620490911500_B39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41590-018-0209-9","article-title":"NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development","volume":"19","author":"Jelencic","year":"2018","journal-title":"Nat. Immunol."},{"key":"2021111620490911500_B40","doi-asserted-by":"publisher","first-page":"e0135874","DOI":"10.1371\/journal.pone.0135874","article-title":"Natural killer p46 controls hepatitis B virus replication and modulates liver inflammation","volume":"10","author":"Li","year":"2015","journal-title":"PloS ONE"},{"key":"2021111620490911500_B41","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jhep.2010.11.030","article-title":"Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance","volume":"55","author":"Alter","year":"2011","journal-title":"J. Hepatol."},{"key":"2021111620490911500_B42","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.4049\/jimmunol.174.3.1213","article-title":"Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo","volume":"174","author":"Vosshenrich","year":"2005","journal-title":"J. Immunol."},{"key":"2021111620490911500_B43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.immunol.24.021605.090727","article-title":"Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis","volume":"24","author":"Ma","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"2021111620490911500_B44","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1182\/blood.V84.12.4008.bloodjournal84124008","article-title":"Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes","volume":"84","author":"Trinchieri","year":"1994","journal-title":"Blood"},{"key":"2021111620490911500_B45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/cmi.2013.1","article-title":"Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology","volume":"10","author":"Harizi","year":"2013","journal-title":"Cell Mol. Immunol."},{"key":"2021111620490911500_B46","doi-asserted-by":"publisher","first-page":"1215.e8","DOI":"10.1016\/j.immuni.2020.10.020","article-title":"Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade","volume":"53","author":"Bonavita","year":"2020","journal-title":"Immunity"},{"key":"2021111620490911500_B47","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.immuni.2020.11.018","article-title":"Tumor-derived PGE2 gives NK cells a headache","volume":"53","author":"Knudsen","year":"2020","journal-title":"Immunity"}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20210600\/915936\/bsr-2021-0600.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20210600\/915936\/bsr-2021-0600.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:33:55Z","timestamp":1699144435000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/41\/7\/BSR20210600\/229068\/Serum-HBV-pregenomic-RNA-exhibited-opposite"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20210600","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7]]},"published":{"date-parts":[[2021,7]]},"article-number":"BSR20210600"}}